Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · CapsoVision, Inc (CV)

CapsoVision sets up $100 million at-the-market share sale program with Cantor Fitzgerald

Neutral Impact 3 of 5 financing Written later

CapsoVision, Inc. entered into a Controlled Equity Offering sales agreement with Cantor Fitzgerald & Co. on August 13, 2026, allowing it to sell up to $100 million of common stock from time to time at its discretion. The filing discloses a legal opinion and registration details but no sales have been reported, and the filing does not state the company's use of proceeds or any financial results.

Key points

  • Sales agreement dated August 13, 2026 with Cantor Fitzgerald & Co. as sales agent or principal
  • Aggregate offering price of up to $100,000,000 of common stock, par value $0.001 per share
  • Shares sold under Form S-3 registration statement (File No. 333-298315) filed August 13, 2026
  • Legal opinion from O'Melveny & Myers LLP dated August 13, 2026, filed as Exhibit 5.1

The filing

CompanyCapsoVision, Inc (CV)
Form8-K, current report
Filed with the SECAug 17, 2026, 5:50 PM ET
Accession number0001378325-26-000039

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 17, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.